|Bid||31.70 x 900|
|Ask||31.75 x 800|
|Day's range||30.82 - 31.89|
|52-week range||30.82 - 81.81|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||83.29|
|Earnings date||19 Feb 2024 - 23 Feb 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||47.75|
With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the...
LAKE FOREST, Calif., November 15, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management will participate in the Stephens Annual Investment Conference on Thursday, November 16, 2023.
STAAR Surgical Company (NASDAQ:STAA) Q3 2023 Earnings Call Transcript November 1, 2023 STAAR Surgical Company beats earnings expectations. Reported EPS is $0.3, expectations were $0.2. Operator: Good day ladies and gentlemen. Thank you for standing by. Welcome to the STAAR Surgical Third Quarter Financial Results Conference Call. During today’s presentation, all parties will be in […]